Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
drug prices
negotiation
pharmacy benefit managers
pricing
senate
abbvie
adalimumab
administration
albert bourla
alex azar
alirocumab
american patients first
What
lower
4
×
drug
prices
awaited
details
house
long
plan
slightly
according
afternoon
anathema
anticipated
away
based
blueprint
bringing
ceos
clinical
company
cost
cut
dc
deb
debuted
democrat
developing
drugs
elements
estimated
executives
filings
friday
fund
gathered
groups
hearing
held
injections
ipo
Language
unset
Current search:
lower
×
biotech
×
@techcrunch.com
2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
